Isabelle Lebeurier

Isabelle Lebeurier, PhD, currently serves as Director of Clinical Operations for Gene Therapy focused on Neurodegenerative and Rare Diseases at Asklepios BioPharmaceutical, Inc. since September 2021, following a position as Senior Clinical Project Manager at Genethon where the focus was on gene therapy for Duchenne Muscular Dystrophy. Previous roles include Senior Global Clinical Project Manager at HAYS LIFE SCIENCES CONSULTING dedicated to Sanofi, along with significant experience at Sanofi itself and Hays Pharma managing global phase III studies across multiple therapeutic areas. Early career experience includes coordinating international studies for Kendle Intl and a trainee role at GSK. Isabelle holds multiple advanced degrees including a Post-Doc from the University of California, San Francisco, and a PhD in Cellular & Molecular Biology from University Paris Diderot- Paris VII.